My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 891

    1.

    Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.

    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA.

    Diabetes. 2001 Aug;50(8):1927-37.PMID: 11473057 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve.

    Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA.

    Int J Exp Diabetes Res. 2000;1(2):131-43.PMID: 11469397 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.

    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Salvemini D, Yorek MA.

    Br J Pharmacol. 2001 Sep;134(1):21-9.PMID: 11522593 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.

    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):49-56.PMID: 11921418 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.

    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.

    Int J Exp Diabetes Res. 2002;3(1):21-36.PMID: 11900277 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction.

    Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Lund DD.

    Exp Diabesity Res. 2004 Apr-Jun;5(2):123-35.PMID: 15203883 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation.

    Coppey LJ, Gellett JS, Davidson EP, Yorek MA.

    Free Radic Res. 2003 Jan;37(1):33-40.PMID: 12653215 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function.

    Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Bing X, Lund DD, Dillon JS.

    Am J Physiol Endocrinol Metab. 2002 Nov;283(5):E1067-75.PMID: 12376336 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.

    Terata K, Coppey LJ, Davidson EP, Dunlap JA, Gutterman DD, Yorek MA.

    Br J Pharmacol. 1999 Oct;128(3):837-43.PMID: 10516670 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats.

    Cameron NE, Cotter MA, Jack AM, Basso MD, Hohman TC.

    Diabetologia. 1999 Sep;42(9):1120-30.PMID: 10447525 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state.

    van Dam PS, van Asbeck BS, Van Oirschot JF, Biessels GJ, Hamers FP, Marx JJ.

    Eur J Clin Invest. 2001 May;31(5):417-24.PMID: 11380593 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.

    Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M.

    Metabolism. 1992 Oct;41(10):1081-6.PMID: 1328819 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats.

    Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, Naruse K, Nakashima W, et al.

    Prostaglandins. 1995 Jun;49(6):339-49.PMID: 7480803 [PubMed - indexed for MEDLINE]Related articles

    14.

    Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.

    Koçak G, Aktan F, Canbolat O, Ozoğul C, Elbeğ S, Yildizoglu-Ari N, Karasu C; ADIC Study Group--Antioxidants in Diabetes-Induced Complications.

    Diabetes Nutr Metab. 2000 Dec;13(6):308-18.PMID: 11232755 [PubMed - indexed for MEDLINE]Related articles

    15.

    Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats.

    Sonobe M, Yasuda H, Hisanaga T, Maeda K, Yamashita M, Kawabata T, Kikkawa R, Taniguchi Y, Shigeta Y.

    Diabetes. 1991 Jun;40(6):726-30.PMID: 1645681 [PubMed - indexed for MEDLINE]Related articles

    16.

    Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.

    Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK.

    Diabetologia. 1994 May;37(5):449-59.PMID: 8056181 [PubMed - indexed for MEDLINE]Related articles

    17.

    Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat.

    Stevens MJ, Lattimer SA, Feldman EL, Helton ED, Millington DS, Sima AA, Greene DA.

    Metabolism. 1996 Jul;45(7):865-72.PMID: 8692023 [PubMed - indexed for MEDLINE]Related articles

    18.

    Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.

    Obrosova IG, Pacher P, Szabó C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MA.

    Diabetes. 2005 Jan;54(1):234-42.PMID: 15616034 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.

    Maxfield EK, Cameron NE, Cotter MA, Dines KC.

    Diabetologia. 1993 Dec;36(12):1230-7.PMID: 8307249 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.

    Davidson EP, Kleinschmidt TL, Oltman CL, Lund DD, Yorek MA.

    Diabetes. 2007 Feb;56(2):355-62.PMID: 17259379 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity